
–As 4th APDA Assembly holds in Lagos
Pharmaceutical distributors across Africa have called for stronger collaboration among countries, regulators and other stakeholders to secure the continent’s medicine supply chains and curb the circulation of falsified and substandard medicines.
They made the call at the ongoing 4th Thematic General Assembly of the African Pharmaceutical Distribution Association (APDA), hosted by the Pharmaceutical Wholesalers and Distributors Association of Nigeria (PWDAN) in Lagos.
The three-day assembly, which began on 6 October at Lagos Marriott Hotel, Ikeja, is themed, “Advancing Pharmaceutical Distribution in Africa: Building Secure Supply Chains Against Falsified Medicines.”
Speaking at the programme, PWDAN Chairman, Pharm. Ogheneochuko Omaruaye, said the fight against falsified medicines could no longer be addressed by individual countries in isolation, stressing the need for coordinated action across Africa.
Omaruaye said the movement of pharmaceutical products across national borders made collaboration among African countries particularly important, as weaknesses in one country’s distribution system could create opportunities for falsified medicines to enter other markets.
He said the objective should be to ensure that medicines maintained their integrity from the point of manufacture through the distribution chain until they reached the final user, calling for stronger regulatory oversight and support for legitimate distributors.
Also speaking, immediate past PWDAN Chairman, Pharm. Ernest Okafor, stressed the importance of stronger regulatory collaboration among African countries in tackling common challenges in pharmaceutical distribution.
Okafor said the continent needed a more unified approach to regulation, noting that fragmented regulatory systems could make it difficult to effectively tackle the movement of falsified and substandard medicines across borders.
Representing APDA President, Dr Lahcen Senhaji, APDA vice president for Central Africa, Dr Yolande Djomo, said the challenges confronting pharmaceutical distribution were largely shared across African countries.
Djomo said the assembly provided an opportunity for stakeholders from different countries to exchange experiences and develop practical solutions, particularly in dealing with informal medicine markets, falsified products and weaknesses in supply-chain security.
She also highlighted the potential of technology, including artificial intelligence, to improve efficiency, traceability and monitoring within the pharmaceutical supply chain.
Chairman of the Conference Planning Committee, Pharm. Bayo Afon, said the assembly was designed to provide a platform for pharmaceutical distributors across Africa to share experiences and develop stronger partnerships in addressing challenges confronting the sector.
Afon said the gathering had attracted stakeholders from different parts of Africa, providing an opportunity for participants to learn from one another and explore ways of strengthening pharmaceutical distribution across national borders.
He noted that the APDA assembly had previously been hosted by other African countries before Nigeria secured the opportunity to host the fourth edition, describing the event as an important platform for advancing the interests of pharmaceutical distribution on the continent.
A major highlight of the ongoing assembly was a facility visit by PWDAN and APDA delegates to World Wide Commercial Ventures (WWCV) in Lagos, where participants expressed admiration for the company’s facilities, organisation and operational standards.

Managing Director of World Wide Healthcare, Mr Naveen Pala, who received the delegates, expressed delight at the visit and briefed them on the company’s improvements, development and continuing efforts to maintain high standards.
The visit provided the delegates with a practical demonstration of modern pharmaceutical distribution and the importance of appropriate infrastructure, storage conditions and professional handling in maintaining the integrity of medicines throughout the supply chain.
The conference continues today with further technical sessions and discussions aimed at strengthening pharmaceutical distribution and securing medicine supply chains across Africa.





